Abstract
576P Clonality of both EGFR and co-occurring TP53 mutations affect the treatment efficacy of the third-generation EGFR-TKIs in advanced-stage EGFR-mutant non-small cell lung cancer
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have